ACADIA Pharmaceuticals
ACAD
#3635
Rank
A$5.14 B
Marketcap
A$30.19
Share price
-3.35%
Change (1 day)
10.67%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): A$0.21 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.07 Billion. a decrease over its 2024 earnings that were of A$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 A$0.20 B-46.18%
2024 A$0.37 B-605.67%
2023 -A$74.26 Million-76.09%
2022 -A$0.32 Billion27.41%
2021 -A$0.25 Billion-40.38%
2020 -A$0.41 Billion19.88%
2019 -A$0.35 Billion-3.92%
2018 -A$0.36 Billion-15.04%
2017 -A$0.42 Billion6.33%
2016 -A$0.4 Billion64.55%
2015 -A$0.24 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$55.22 Million81.93%
2012 -A$30.35 Million-8.73%
2011 -A$33.25 Million-251.39%
2010 A$21.96 M-133.2%
2009 -A$66.16 Million-30.82%
2008 -A$95.63 Million6.43%
2007 -A$89.85 Million25.89%
2006 -A$71.37 Million36.99%
2005 -A$52.1 Million37.22%
2004 -A$37.97 Million19.96%
2003 -A$31.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.81 B 24,054.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.82 B 7,237.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.43 B 18,424.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B 6,615.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.18 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$56.21 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA